Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RFL |
---|---|---|
09:32 ET | 388 | 1.57 |
09:39 ET | 1283 | 1.58 |
09:41 ET | 125 | 1.588 |
09:52 ET | 1870 | 1.575 |
10:01 ET | 162 | 1.59 |
10:35 ET | 100 | 1.57 |
10:42 ET | 400 | 1.6 |
10:53 ET | 109 | 1.63 |
10:55 ET | 5202 | 1.581 |
11:00 ET | 100 | 1.55 |
11:22 ET | 631 | 1.585 |
11:42 ET | 100 | 1.57 |
12:03 ET | 100 | 1.57 |
12:07 ET | 235 | 1.575 |
12:14 ET | 300 | 1.58 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Rafael Holdings Inc | 38.6M | 18.1x | --- |
Presidential Realty Corp | 14.2K | 0.0x | --- |
Palmetto Real Estate Trust | 13.3M | 27.6x | +3.53% |
Power REIT | 2.4M | -0.1x | --- |
Medalist Diversified Reit Inc | 13.0M | -6.4x | --- |
Pillarstone Capital REIT | 9.9K | 0.0x | --- |
Rafael Holdings, Inc. is a holding company with interests in clinical and early-stage pharmaceutical companies. The Company's segments include healthcare and real estate. The Company's investments include Cornerstone Pharmaceuticals, Inc., which is a cancer metabolism-based therapeutics company; LipoMedix Pharmaceuticals Ltd., which is a clinical-stage pharmaceutical company; Barer Institute Inc., which is a preclinical cancer metabolism research operation; Cyclo Therapeutics Inc., which is a clinical-stage biotechnology company dedicated to developing medicines for patients and families living with diseases through its therapeutic asset like Trappsol and Cyclo; Day Three Labs, Inc., which offers pharmaceutical-grade technology like Unlokt, and Rafael Medical Devices, LLC, which is an orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries. Its real estate segment comprises of a portion of a commercial building in Israel.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $38.6M |
---|---|
Revenue (TTM) | $275.0K |
Shares Outstanding | 24.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.31 |
EPS | $0.09 |
Book Value | $4.13 |
P/E Ratio | 18.1x |
Price/Sales (TTM) | 140.4 |
Price/Cash Flow (TTM) | 14.7x |
Operating Margin | -4,729.82% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.